170 related articles for article (PubMed ID: 2571488)
1. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
Murray M; Reidy GF
Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
3. Selective reactivation of steroid hydroxylases following dissociation of the isosafrole metabolite complex with rat hepatic cytochrome P-450.
Murray M; Zaluzny L; Farrell GC
Arch Biochem Biophys; 1986 Dec; 251(2):471-8. PubMed ID: 3800378
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
Ng SF; Waxman DJ
Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
[TBL] [Abstract][Full Text] [Related]
5. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis.
Murray M; Zaluzny L; Dannan GA; Guengerich FP; Farrell GC
Mol Pharmacol; 1987 Jan; 31(1):117-21. PubMed ID: 3543647
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
Miller NE; Halpert JR
Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cytochrome P-450c-mediated benzo[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole.
Kao LR; Wilkinson CF
Xenobiotica; 1987 Jul; 17(7):793-805. PubMed ID: 3660849
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes.
Murray M; Hetnarski K; Wilkinson CF
Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165
[TBL] [Abstract][Full Text] [Related]
9. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
Jeffery EH; Mannering GJ
Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
[TBL] [Abstract][Full Text] [Related]
10. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
Murray M
Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene.
Cresteil T; Beaune P; Celier C; Leroux JP; Guengerich FP
J Pharmacol Exp Ther; 1986 Jan; 236(1):269-76. PubMed ID: 3941398
[TBL] [Abstract][Full Text] [Related]
13. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
Bast A; Savenije-Chapel EM; Kroes BH
Xenobiotica; 1984 May; 14(5):399-408. PubMed ID: 6089451
[TBL] [Abstract][Full Text] [Related]
15. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
Bornheim LM; Franklin MR
Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.
Chang T; Levine M; Bandiera SM; Bellward GD
J Pharmacol Exp Ther; 1992 Mar; 260(3):1441-9. PubMed ID: 1545403
[TBL] [Abstract][Full Text] [Related]
17. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
18. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
Halpert J; Balfour C; Miller NE; Morgan ET; Dunbar D; Kaminsky LS
Mol Pharmacol; 1985 Sep; 28(3):290-6. PubMed ID: 4033629
[TBL] [Abstract][Full Text] [Related]
19. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
Stevens JC; Halpert J
Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
[TBL] [Abstract][Full Text] [Related]
20. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
Murray M; Butler AM
J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
